103 related articles for article (PubMed ID: 17944867)
1. Protein misfolding and disease: the case of prion disorders.
Hetz C; Soto C
Cell Mol Life Sci; 2003 Jan; 60(1):133-43. PubMed ID: 12613663
[TBL] [Abstract][Full Text] [Related]
2. The intriguing prion disorders.
Abid K; Soto C
Cell Mol Life Sci; 2006 Oct; 63(19-20):2342-51. PubMed ID: 16927029
[TBL] [Abstract][Full Text] [Related]
3. The Pathogenic A116V Mutation Enhances Ion-Selective Channel Formation by Prion Protein in Membranes.
Sabareesan AT; Singh J; Roy S; Udgaonkar JB; Mathew MK
Biophys J; 2016 Apr; 110(8):1766-1776. PubMed ID: 27119637
[TBL] [Abstract][Full Text] [Related]
4. Biophysical and morphological studies on the dual interaction of non-octarepeat prion protein peptides with copper and nucleic acids.
Chaves JA; Sanchez-López C; Gomes MP; Sisnande T; Macedo B; de Oliveira VE; Braga CA; Rangel LP; Silva JL; Quintanar L; Cordeiro Y
J Biol Inorg Chem; 2014 Aug; 19(6):839-51. PubMed ID: 24557708
[TBL] [Abstract][Full Text] [Related]
5. Recovery of small infectious PrP(res) aggregates from prion-infected cultured cells.
Anaya ZEA; Savistchenko J; Massonneau V; Lacroux C; Andréoletti O; Vilette D
J Biol Chem; 2011 Mar; 286(10):8141-8148. PubMed ID: 21212268
[TBL] [Abstract][Full Text] [Related]
6. Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.
Harrison CF; Lawson VA; Coleman BM; Kim YS; Masters CL; Cappai R; Barnham KJ; Hill AF
J Biol Chem; 2010 Jun; 285(26):20213-23. PubMed ID: 20356832
[TBL] [Abstract][Full Text] [Related]
7. Prion protein-detergent micelle interactions studied by NMR in solution.
Hornemann S; von Schroetter C; Damberger FF; Wüthrich K
J Biol Chem; 2009 Aug; 284(34):22713-21. PubMed ID: 19546219
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxic species in prion disease: a role for PrP isoforms?
Harrison CF; Barnham KJ; Hill AF
J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867
[TBL] [Abstract][Full Text] [Related]
9. Human prion diseases: molecular and clinical aspects.
Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
[TBL] [Abstract][Full Text] [Related]
10. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
[TBL] [Abstract][Full Text] [Related]
11. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
12. [What are the prions?].
Piédrola Angulo G
An R Acad Nac Med (Madr); 2001; 118(3):599-604. PubMed ID: 11783039
[No Abstract] [Full Text] [Related]
13. The state of the prion.
Weissmann C
Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
